Advertisement
News
Subscribe to MDT Magazine News

Mindray Medical shares fall on 2Q revenue miss

August 10, 2010 11:45 am | by The Associated Press | Comments

Shares of China's Mindray Medical International Ltd. tumbled sharply Tuesday after the medical device maker posted weaker-than-expected revenue for the second quarter and trimmed its full-year forecast."While we achieved better-than-expected international sales, lower-than-expected government...

S & P shuffles SmallCap 600 index, shares get boost

August 10, 2010 10:45 am | by The Associated Press | Comments

Standard & Poor's gave a boost to the stocks of three companies after it announced plans to add them to its SmallCap 600 index.S&P said it will make the following changes:— Orion Marine Group Inc. will replace Odyssey HealthCare Inc. after the close of trading on Monday. Shares of the marine...

Vertex: Shorter therapy with hep C drug is OK

August 10, 2010 10:37 am | by Mass High Tech: The Journal of New England Technology | Comments

Vertex Pharmaceuticals Inc. has announced that a late-stage clinical trial has found that doubling the length of therapy for its hepatitis C drug candidate does not substantially increase the benefit.

Advertisement

Another buyout adds to iMedx med transcription leadership

August 10, 2010 10:36 am | by Mass High Tech: The Journal of New England Technology | Comments

Medical transcription firm iMedX Inc., of Shelton, Conn., has announced its acquisition of Louisiana-based MedTech Transcriptions Inc. The buyout is the fifth acquisition iMedX has completed in 12 months.

Study Shows Physicians Reluctant to Use Chemoprevention for Prostate Cancer -

August 10, 2010 10:33 am | by AACR | Comments

• Use of finasteride for prostate cancer prevention has not increased. • Experts expect a slow adoption of chemoprevention strategies. PHILADELPHIA - Despite the dramatic results of the Prostate Cancer Prevention Trial (PCPT), which showed a significant reduction in prostate cancer among...

TOPICS:

New Findings Further Clarify Breast Cancer Risk With Hormone Therapy

August 10, 2010 10:33 am | by AACR | Comments

• Risk varied according to BMI, with greater risks for thinner women. • Longer duration of hormone therapy increased breast cancer risk. PHILADELPHIA - A new analysis of the California Teachers Study, which analyzed hormone replacement therapy use among 2,857 women for almost 10 years,...

TOPICS:

Miller joins Concert Pharma's corporate leadership team

August 10, 2010 9:38 am | by Mass High Tech: The Journal of New England Technology | Comments

Lexington-based Concert Pharmaceuticals Inc. has named Gregory Miller, a former senior director of business development and corporate strategy at AMAG Pharmaceuticals Inc., as its head of business and corporate development.

Teleflex closes $400M sale of senior notes

August 10, 2010 8:45 am | by The Associated Press | Comments

Teleflex Inc. said Tuesday it sold $400 million in senior notes, and used the proceeds to prepay debt and fund convertible bond hedge bond transactions.Teleflex's new senior notes are due in 2017. The total includes $50 million in notes purchased by the underwriters of its offering. The company...

Advertisement

NIH EUREKA Award Will Enable Design of New Brain Tumor Treatment

August 10, 2010 8:36 am | by Georgia Tech Institute of Technology | Comments

The Georgia Institute of Technology has received a EUREKA grant from the National Cancer Institute to design a new way to treat invasive brain tumors by capturing the migrating cells that spread the disease.

TOPICS:

NeuroMetrix 2Q loss widens as revenue sinks

August 10, 2010 7:45 am | by The Associated Press | Comments

Medical device maker NeuroMetrix Inc. said Tuesday its second-quarter loss deepened, as a change in Medicare reimbursement hurt revenue, which fell more than 40 percent.The Waltham, Mass., company said it lost $4.5 million, or 20 cents per share, in the three months that ended June 30. That...

Penwest to be bought by Endo Pharmaceuticals

August 10, 2010 7:37 am | by Mass High Tech: The Journal of New England Technology | Comments

Penwest Pharmaceuticals Co. has agreed to be acquired by 13-year partner Endo Pharmaceuticals Holdings Co. for about $144 million. Penwest develops extended-release drug delivery technology used in Opana ER, a pain killer launched and commercialized by Endo.

Solar Energy Initiatives, Inc. Appoints Mr. Jack Zwick to Its Board of Directors

August 10, 2010 6:45 am | by The Associated Press | Comments

http://www.solarenergyinitiatives.com () —Solar Energy Initiatives, Inc. (OTCBB: SNRY), with businesses in solar project development, distribution and workforce training, today announced the appointment of Mr. Jack Zwick, CPA to its Board of Directors. The appointment comes at a vital time...

Exogenesis bumps financing up to $4.5M

August 10, 2010 6:37 am | by Mass High Tech: The Journal of New England Technology | Comments

Exogenesis Corp., a gas cluster ion beam technology firm in Billerica, has raised $4.5 million in an amended equity offering. The company uses the GCIB technology to process implantable medical devices.

Neurochip technology developed by Canadian team

August 10, 2010 6:35 am | by EurekAlert | Comments

(University of Calgary) The University of Calgary, Faculty of Medicine scientists who proved it is possible to cultivate a network of brain cells that reconnect on a silicon chip -- or the brain on a microchip -- have been involved in the development of new technology that monitors brain...

TOPICS:

Regional protocols improve quality of care for aortic dissection patients

August 10, 2010 6:35 am | by EurekAlert | Comments

(Minneapolis Heart Institute Foundation) Using a standardized protocol within a regional health network, a multidisciplinary acute aortic dissection program resulted in a 43 percent reduction in time to diagnosis for all AAD patients over the course of five years, based on study results...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading